Dow Up 0.08% Nasdaq Down 0.30%

Celgene Corporation (CELG)

-NasdaqGS
93.85 Up 0.58(0.62%) Sep 19, 4:00PM EDT
|After Hours : 93.55 Down 0.30 (0.32%) Sep 19, 6:56PM EDT
Prev Close:93.27
Open:94.45
Bid:93.51 x 300
Ask:94.20 x 300
1y Target Est:102.69
Beta:1.1
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:93.34 - 94.96
52wk Range:66.85 - 96.44
Volume:6,051,273
Avg Vol (3m):4,444,690
Market Cap:75.03B
P/E (ttm):29.87
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 0.62%75.03B
JNJUp 0.60%304.56B

Key Statistics

Forward P/E (1 yr):19.19
P/S (ttm):10.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.68
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.96

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback